Simponi and Swallowing difficulty - a phase IV clinical study of FDA data
We study 78,881 people who have side effects when taking Simponi. Swallowing difficulty is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Enbrel and have Dizziness.
The phase IV clinical study analyzes which people take Simponi and have Swallowing difficulty. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
78,881 people reported to have side effects when taking Simponi.
Among them, 115 people (0.15%) have Swallowing difficulty.
What is Simponi?
Simponi has active ingredients of golimumab. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 79,099 Simponi users.
What is Swallowing difficulty?
Swallowing difficulty is found to be associated with 3,509 drugs and 3,237 conditions by eHealthMe. Currently, we are studying 105,423 people who have Swallowing difficulty.
Number of Simponi and Swallowing difficulty reports submitted per year:
Time on Simponi when people have Swallowing difficulty *:
Gender of people who have Swallowing difficulty when taking Simponi*:
Age of people who have Swallowing difficulty when taking Simponi *:
Common drugs people take besides Simponi *:
Common side effects people have besides Swallowing difficulty *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Simponi and have Swallowing difficulty?Check whether Swallowing difficulty is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
Simponi side effects by duration, gender and age:
- Simponi side effects (79,099 reports)
Swallowing difficulty treatments and more:
- Swallowing difficulty (105,423 reports)
Common drugs associated with Swallowing difficulty:
- Aspirin: 5,224 reports
- Prednisone: 4,850 reports
- Omeprazole: 3,411 reports
- Lisinopril: 2,968 reports
- Synthroid: 2,763 reports
- Nexium: 2,717 reports
- Methotrexate: 2,673 reports
- Gabapentin: 2,603 reports
- Pantoprazole: 2,583 reports
- Fosamax: 2,539 reports
All the drugs that are associated with Swallowing difficulty:
- Swallowing difficulty (3,509 drugs)
Common conditions associated with Swallowing difficulty:
- High blood pressure: 5,178 reports
- Multiple sclerosis: 4,150 reports
- Pain: 3,517 reports
- Parkinson's disease: 2,975 reports
- Depression: 2,828 reports
All the conditions that are associated with Swallowing difficulty:
- Swallowing difficulty (3,237 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on golimumab (the active ingredients of Simponi) and Simponi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ramipril and Bisoprolol Fumarate drug interaction - 4 seconds ago
- Lamictal and Activated Charcoal drug interaction - 8 seconds ago
- Orphenadrine Citrate and Opana drug interaction - 16 seconds ago
- Calciparine and Idiopathic Or Primary Livedo Reticularis - 17 seconds ago
- Nortrel 7/7/7 and Metformin drug interaction - 34 seconds ago
- Cefpodoxime Proxetil and Hygroton drug interaction - 35 seconds ago
- Hydroxychloroquine Sulfate and Respiratory Rate Increased - a minute ago
- Ferrous Fumarate and Motrin drug interaction - a minute ago
- Infed and Potassium Chloride drug interaction - a minute ago
- Metrocream and Nexavar drug interaction - a minute ago